Volume : 10, Issue : 02, February – 2023

Title:

49.STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE DETERMINATION OF GEFITINIB IN BULK FORM AND MARKETED PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC
‬

Authors :

Nerella Naveen Kumar*, Naveen Kumar Singhal

Abstract :

A simple, reproducible, and efficient reverse phase high performance liquid chromatographic method was developed for determination of Gefitinib in pure form and marketed pharmaceutical dosage forms. A column having Kromasil C18, 250 mm x 4.6 mm i.d.5µm particle size in isocratic mode with mobile phase containing Methanol: Acetonitrile (65:35 v/v) was used. The flow rate was 1.0 ml/min, and the effluent was monitored at 245 nm. The retention time (min) and linearity range (ppm) for Gefitinib were (2.800 min) and (6-14µg/ml) respectively. The method has been validated for linearity, accuracy, and precision, robustness, and limit of detection, and limit of quantitation. The limit of detection (LOD) and limit of quantification (LOQ) were found to be 0.507μg/ml and 1.539μg/ml for Gefitinib respectively. The developed method was found to be accurate, precise and selective for determination of Gefitinib in bulk and marketed pharmaceutical dosage form.
Key Words: Gefitinib, RP-HPLC, Accuracy, Precision, Robustness, ICH Guidelines.

Cite This Article:

Number of Downloads : 10

References:

1. Sandhya Mohan Varasala, Kuna Mangamma, Analytical Method Development and Validation for the Estimation of Gefitinib by Rp-Hplc Method in Tablet Dosage Form, International Journal of Pharmacy and Biological Sciences, IJPBS |Volume 3| Issue 4 |OCT-DEC|2013|198-201.
2. M. Alagar Raja*1, P. Joshna1, David Banji1, K. N. V. Rao1, D. Selva Kumar D2, Analytical Method Development and Validation of Gefitinib (Anti – Cancer Drug) in Pharmaceutical Tablet Dosage Form By Using RP-HPLC, Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry. 2(3), 2014, 127 – 133.
3. PVV Satyanarayana1 and M. Murali2*, Development and Validation of LC Method for the Estimation of Gefitinib in Pharmaceutical Dosage Form, International Journal of Research in Pharmacy and Chemistry, IJRPC 2011, 1(3), Pages: 338-341.
4. A. Sreedevi, A. Lakshmana Rao* and L. Kalyani, Development and Validation of Stability Indicating HPLC Method for Estimation of Gefitinib in Bulk and its Pharmaceutical Formulations, International Journal of Pharmaceutical, Chemical and Biological Sciences, IJPCBS 2013, 3(4), 1305-1314.
5. Santhosh Illendula, Naveen Kumar Singhal; A Review: Novel analytical method development and validation for the determination of selected anti cancer & anti viral drugs, World Journal of Pharmacy and Pharmaceutical Sciences 2022; 11(07):533-566.
6. Santhosh Illendula, M. Sanjana & Rajeswar Dutt ; A validated stability indicating RP_HPLC method development for the estimation of pomalidomide in bulk & pharmaceutical dosage form , Int. J. Pharm. Biol. Sci IJPBS 09(01) 2019, 63-72.
7. https://go.drugbank.com/drugs/DB00317
8. https://pubchem.ncbi.nlm.nih.gov/compound/Gefitinib
9. https://en.wikipedia.org/wiki/Gefitinib